Unlocking Cost-Efficient Biopharma Innovation with Unused and Used Equipment Why Unused or Slightly Used High-End Equipment Is Often Overlooked The U.S. biopharma industry faces increasing competition from China’s rapid expansion, while NIH cost caps are poised to impact funding for R&D. As investors and innovators look to stretch every dollar further, events like the 2025 BIO...